A detailed history of Virtus ETF Advisers LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 7,542 shares of LEGN stock, worth $301,906. This represents 0.17% of its overall portfolio holdings.

Number of Shares
7,542
Previous 6,207 21.51%
Holding current value
$301,906
Previous $348,000 4.02%
% of portfolio
0.17%
Previous 0.19%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $52,732 - $76,388
1,335 Added 21.51%
7,542 $334,000
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $49,168 - $62,501
893 Added 16.8%
6,207 $348,000
Q4 2023

Feb 15, 2024

BUY
$57.25 - $69.74 $51,811 - $63,114
905 Added 20.53%
5,314 $319,000
Q3 2023

Nov 07, 2023

SELL
$63.16 - $76.5 $36,190 - $43,834
-573 Reduced 11.5%
4,409 $296,000
Q2 2023

Aug 14, 2023

SELL
$46.28 - $75.01 $44,243 - $71,709
-956 Reduced 16.1%
4,982 $343,000
Q1 2023

May 15, 2023

BUY
$43.42 - $57.37 $4,602 - $6,081
106 Added 1.82%
5,938 $286,000
Q4 2022

Feb 14, 2023

BUY
$38.8 - $55.46 $18,662 - $26,676
481 Added 8.99%
5,832 $291,000
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $2,937 - $4,396
77 Added 1.46%
5,351 $218,000
Q2 2022

Aug 12, 2022

BUY
$33.54 - $55.0 $69,729 - $114,345
2,079 Added 65.07%
5,274 $290,000
Q1 2022

May 16, 2022

SELL
$31.02 - $48.18 $5,862 - $9,106
-189 Reduced 5.59%
3,195 $116,000
Q4 2021

Feb 14, 2022

SELL
$41.14 - $56.98 $77,384 - $107,179
-1,881 Reduced 35.73%
3,384 $158,000
Q3 2021

Nov 15, 2021

SELL
$35.31 - $50.56 $9,392 - $13,448
-266 Reduced 4.81%
5,265 $266,000
Q2 2021

Aug 10, 2021

SELL
$25.8 - $41.09 $115,713 - $184,288
-4,485 Reduced 44.78%
5,531 $227,000
Q1 2021

May 17, 2021

BUY
$23.55 - $32.4 $4,286 - $5,896
182 Added 1.85%
10,016 $291,000
Q4 2020

Feb 12, 2021

BUY
$25.8 - $32.39 $253,717 - $318,523
9,834 New
9,834 $277,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.